Blaise_logo_splashBlaise_logo_splashBlaise_logo_splashBlaise_logo_splash
  • Home
  • About
    • Overview
    • Market Expertise
      • Biotechnology
      • Pharmaceuticals
      • Medical Devices
      • Contract Services
    • Letter From the Chairman
  • Search Services
    • Search Services
    • CEO
    • Board
    • Executive
    • Sample Placements
  • Search Process
    • Search Process
    • Step-By-Step
    • Diversity Initiatives
    • Succession Planning
  • Strategic Services
  • Client Login
  • Candidate Login
  • News & Events
    • News
    • Events
  • Contact
✕
Genmab Seeks $405M from Janssen in Arbitration Over Royalty Payments
June 10, 2022
Fierce Pharma Asia—Enhertu’s standing ovation; Tessa’s $126M CAR-T financing; Samsung’s manufacturing deal
June 10, 2022
Genmab Seeks $405M from Janssen in Arbitration Over Royalty Payments
June 10, 2022
Fierce Pharma Asia—Enhertu’s standing ovation; Tessa’s $126M CAR-T financing; Samsung’s manufacturing deal
June 10, 2022
0
Published by at June 10, 2022
Categories
Tags

The European Hematology Association’s 2022 Hybrid Congress is in full swing in Vienna, Austria and will feature the newest and most promising developments in blood cancer research.

CALIFORNIA

Blaise Group International 
Corporate Headquarters

101 Pacifica, Suite 280
Irvine, CA 92618
Telephone: +1 (949) 502-4070
Fax: +1 (949) 502-4069
[email protected]

NEW YORK

Blaise Group International
New York
New York Rockefeller Center
1 Rockefeller Plz, FL 11
New York, NY 10020
Telephone: +1 (917) 588-3700
Fax: +1 (212) 618-6309
[email protected]

LONDON

 Blaise Group International
London

Berkeley Square House
Berkeley Square 2nd Floor
London W1J6BD United Kingdom
Telephone: +44 20 7887 6197
Fax: +44 20 7887 6001
[email protected]

Contact Us

  • This field is for validation purposes and should be left unchanged.

© 2017 Blaise Group International All rights reserved. Orange County Web Design by LightHouse Graphics